These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 30802466)

  • 21. Current European data collection on emergency department presentations with acute recreational drug toxicity: gaps and national variations.
    Heyerdahl F; Hovda KE; Giraudon I; Yates C; Dines AM; Sedefov R; Wood DM; Dargan PI
    Clin Toxicol (Phila); 2014 Dec; 52(10):1005-12. PubMed ID: 25361166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Designer benzodiazepines versus prescription benzodiazepines: can structural relation predict the next step?
    Moustafa RE; Tarbah F; Saeed HS; Sharif SI
    Crit Rev Toxicol; 2021 Mar; 51(3):249-263. PubMed ID: 34038656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Detoxification after use of new psychoactive substances purchased online].
    Frost J; Mikkelsen T; Andersen MN; Bjerke HA; Gundersen POM; Aamo TO
    Tidsskr Nor Laegeforen; 2024 Mar; 144(4):. PubMed ID: 38506014
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New Psychoactive Substances consumption and their monito- ring during Covid-19 pandemic.
    Di Trana A; La Maida N
    Clin Ter; 2021 Jul; 172(4):271-272. PubMed ID: 34247209
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Designer benzodiazepines: an update.
    Yu X; Greenblatt HK; Greenblatt DJ
    Expert Rev Clin Pharmacol; 2023 Feb; 16(2):109-117. PubMed ID: 36649662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The synthetic cathinone α-pyrrolidinovalerophenone (α-PVP): pharmacokinetic and pharmacodynamic clinical and forensic aspects.
    Nóbrega L; Dinis-Oliveira RJ
    Drug Metab Rev; 2018 May; 50(2):125-139. PubMed ID: 29540067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Death cases involving certain new psychoactive substances: A review of the literature.
    Kraemer M; Boehmer A; Madea B; Maas A
    Forensic Sci Int; 2019 May; 298():186-267. PubMed ID: 30925344
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phantom menace: novel psychoactive substances and the UK Armed Forces.
    Hunter AH; Ayres T; Moreland N; Cox A
    J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recreational drugs: the complication's pleasure?].
    Joye F; Donzé N; Frochaux V; Niquille M; Selz Amaudruz F
    Rev Med Suisse; 2013 Aug; 9(394):1454-60. PubMed ID: 24024389
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Can one talk of benzodiazepine "drunkenness"? About acute benzodiazepine intoxication, without suicidal or mortiferous tendencies].
    Menecier P; Texier MA; Las R; Ploton L
    Encephale; 2012 Feb; 38(1):25-30. PubMed ID: 22381720
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designer Benzodiazepines: A Review of Toxicology and Public Health Risks.
    Brunetti P; Giorgetti R; Tagliabracci A; Huestis MA; Busardò FP
    Pharmaceuticals (Basel); 2021 Jun; 14(6):. PubMed ID: 34208284
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Survey of current trends in the abuse of psychotropic substances and plants in Japan.
    Kikura-Hanajiri R; Uchiyama N; Goda Y
    Leg Med (Tokyo); 2011 May; 13(3):109-15. PubMed ID: 21377397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-cathinone derivatives--a new generation of dangerous psychostimulant "designer drugs"].
    Zawilska JB; Słomiak K; Wasiak M; Woźniak P; Massalski M; Krupa E; Wojcieszak JŁ
    Przegl Lek; 2013; 70(6):386-91. PubMed ID: 24052975
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Benzodiazepines and Related Sedatives.
    Peng L; Morford KL; Levander XA
    Med Clin North Am; 2022 Jan; 106(1):113-129. PubMed ID: 34823725
    [TBL] [Abstract][Full Text] [Related]  

  • 35. "Not for human consumption": a review of emerging designer drugs.
    Musselman ME; Hampton JP
    Pharmacotherapy; 2014 Jul; 34(7):745-57. PubMed ID: 24710806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic cathinones: an evolving class of new psychoactive substances.
    Gonçalves JL; Alves VL; Aguiar J; Teixeira HM; Câmara JS
    Crit Rev Toxicol; 2019 Aug; 49(7):549-566. PubMed ID: 31747318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.
    Helander A; Beck O; Hägerkvist R; Hultén P
    Scand J Clin Lab Invest; 2013 Aug; 73(5):400-6. PubMed ID: 23692208
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prohibition is a key driver of the new psychoactive substances (NPS) phenomenon.
    Rolles S; Kushlick D
    Addiction; 2014 Oct; 109(10):1589-90. PubMed ID: 25163705
    [No Abstract]   [Full Text] [Related]  

  • 39. Occurrence and time course of NPS benzodiazepines in Sweden - results from intoxication cases in the STRIDA project.
    Bäckberg M; Pettersson Bergstrand M; Beck O; Helander A
    Clin Toxicol (Phila); 2019 Mar; 57(3):203-212. PubMed ID: 30348014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New Psychoactive Substances and Suicidality: A Systematic Review of the Current Literature.
    Chiappini S; Mosca A; Miuli A; Santovito MC; Orsolini L; Corkery JM; Guirguis A; Pettorruso M; Martinotti G; Di Giannantonio M; Schifano F
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34204131
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.